RxDoctor Payments DataLook up a doctor →

David Robertson, MD

Allergy & Immunology · Springfield, MANPI 1265647945

Payments from drug & device makers

$61,619in general payments, 2019–2025

Across 1,207 payments — averaging $51.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$34K
  • GSK$10K
  • AstraZeneca$4K
  • Pfizer$2K
  • Novartis$2K
  • Optinose US, Inc.$1K
  • plus $9K from 34 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Regeneron Healthcare Solutions, Inc.127$34,058
GSK176$10,146
AstraZeneca177$3,789
Pfizer119$1,869
Novartis118$1,505
Optinose US, Inc.18$1,152
CSL Behring64$1,128
Sanofi61$1,104
Genentech USA, Inc.50$921
Takeda Pharmaceuticals U.S.A., Inc.46$873
Amgen(2 entities)46$775
Grifols USA, LLC29$583
Pharming Healthcare, Inc.22$463
Boehringer Ingelheim21$375
AbbVie13$341
Incyte Corporation10$251
Octapharma USA, Inc.12$237
LEO Pharma Inc.9$224
Lilly USA, LLC9$170
Teva Pharmaceuticals USA, Inc.10$165
Blueprint Medicines Corporation5$162
Kaleo, Inc.7$152
Aimmune Therapeutics, Inc.7$152
Shire North American Group Inc7$137
Sanofi-aventis U.S. LLC5$132
GC Biopharma USA, Inc.5$115
Covis Pharma GmbH5$93
ARS Pharmaceuticals Operations, Inc.3$76
Biocryst US Sales Co., LLC4$74
Alk-abello, Inc4$62
Merck4$57
Greer Laboratories, Inc.2$45
Galderma Laboratories, L.p.2$41
Verona Pharma, Inc.2$36
Phadia US Inc.2$31
Azurity Pharmaceuticals, Inc.2$31
Organon1$31
Cycle Pharmaceuticals Inc1$25
Bio Products Laboratory USA, Inc.1$20
Invivyd Inc1$17

How this compares

$61,619 in reported general payments places this provider in the 75th percentile of 114 allergy & immunology providers in Massachusetts.

See all allergy & immunology providers in Massachusetts →

Medicare billing

Part B allowed, 2024
$98,656
Medicare patients
241
Services billed
6,226

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other allergy & immunology in Springfield

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →